122 related articles for article (PubMed ID: 8616947)
1. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study.
Bode-Böger SM; Böger RH; Alfke H; Heinzel D; Tsikas D; Creutzig A; Alexander K; Frölich JC
Circulation; 1996 Jan; 93(1):85-90. PubMed ID: 8616947
[TBL] [Abstract][Full Text] [Related]
2. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
[TBL] [Abstract][Full Text] [Related]
3. Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-name in rats.
Boger RH; Bode-Boger SM; Gerecke U; Gutzki FM; Tsikas D; Frolich JC
Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):11-5. PubMed ID: 8713490
[TBL] [Abstract][Full Text] [Related]
4. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
Böger RH; Bode-Böger SM; Thiele W; Junker W; Alexander K; Frölich JC
Circulation; 1997 Apr; 95(8):2068-74. PubMed ID: 9133517
[TBL] [Abstract][Full Text] [Related]
5. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.
Bode-Böger SM; Böger RH; Galland A; Tsikas D; Frölich JC
Br J Clin Pharmacol; 1998 Nov; 46(5):489-97. PubMed ID: 9833603
[TBL] [Abstract][Full Text] [Related]
6. Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease.
Koifman B; Topilski I; Megidish R; Zelmanovich L; Chernihovsky T; Bykhovsy E; Keren G
Am J Cardiol; 2006 Jul; 98(2):172-7. PubMed ID: 16828587
[TBL] [Abstract][Full Text] [Related]
7. The LargPAD Trial: Phase IIA evaluation of l-arginine infusion in patients with peripheral arterial disease.
Kashyap VS; Lakin RO; Campos P; Allemang M; Kim A; Sarac TP; Hausladen A; Stamler JS
J Vasc Surg; 2017 Jul; 66(1):187-194. PubMed ID: 28366306
[TBL] [Abstract][Full Text] [Related]
8. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects.
Bode-Böger SM; Böger RH; Creutzig A; Tsikas D; Gutzki FM; Alexander K; Frölich JC
Clin Sci (Lond); 1994 Sep; 87(3):303-10. PubMed ID: 7955906
[TBL] [Abstract][Full Text] [Related]
9. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
[TBL] [Abstract][Full Text] [Related]
10. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
11. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure.
Koifman B; Wollman Y; Bogomolny N; Chernichowsky T; Finkelstein A; Peer G; Scherez J; Blum M; Laniado S; Iaina A
J Am Coll Cardiol; 1995 Nov; 26(5):1251-6. PubMed ID: 7594039
[TBL] [Abstract][Full Text] [Related]
12. L-arginine stimulates NO-dependent vasodilation in healthy humans--effect of somatostatin pretreatment.
Bode-Böger SM; Böger RH; Löffler M; Tsikas D; Brabant G; Frölich JC
J Investig Med; 1999 Jan; 47(1):43-50. PubMed ID: 10071480
[TBL] [Abstract][Full Text] [Related]
13. Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure.
Kanaya Y; Nakamura M; Kobayashi N; Hiramori K
Heart; 1999 May; 81(5):512-7. PubMed ID: 10212170
[TBL] [Abstract][Full Text] [Related]
14. Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.
Tajiri K; Miyakawa H; Izumi N; Marumo F; Sato C
Hepatology; 1995 Nov; 22(5):1430-5. PubMed ID: 7590659
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
[TBL] [Abstract][Full Text] [Related]
16. Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1.
Weiss T; Fischer D; Hausmann D; Weiss C
Prostaglandins Leukot Essent Fatty Acids; 2002 Nov; 67(5):277-81. PubMed ID: 12445486
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.
Schwedhelm E; Maas R; Freese R; Jung D; Lukacs Z; Jambrecina A; Spickler W; Schulze F; Böger RH
Br J Clin Pharmacol; 2008 Jan; 65(1):51-9. PubMed ID: 17662090
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenetic aspects of the L-arginine-NO metabolic pathway in arteriosclerosis and possible therapeutic aspects].
Böger RH; Bode-Böger SM; Frölich JC
Vasa; 1996; 25(4):305-16. PubMed ID: 9036707
[TBL] [Abstract][Full Text] [Related]
20. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
